Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein

The drug repurposing strategy has been applied to the development of emergency COVID-19 therapeutic medicines. Current drug repurposing approaches have been directed against RNA polymerases and viral proteases. Recently, we found that the inhibition of the interaction between the SARS-CoV-2 structur...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jinsoo, Hwang, Seok Young, Kim, Dongbum, Kim, Minyoung, Baek, Kyeongbin, Kang, Mijeong, An, Seungchan, Gong, Junpyo, Park, Sangkyu, Kandeel, Mahmoud, Lee, Younghee, Noh, Minsoo, Kwon, Hyung-Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424333/
https://www.ncbi.nlm.nih.gov/pubmed/35548881
http://dx.doi.org/10.4062/biomolther.2022.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424333/
https://www.ncbi.nlm.nih.gov/pubmed/35548881
http://dx.doi.org/10.4062/biomolther.2022.037

Ejemplares similares